EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT

Share · VGG3141W1142 · EUCRU (XNAS)

Overview

No Price

n/a

Share Float & Liquidity

Free Float 33,63 %

Shares Float 1,59 M

Shares Outstanding 4,72 M

Company Profile for EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT Share

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

AI Analysis of EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT

No AI threads available for this company yet.

Company Data

Name EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT

Company Eucrates Biomedical Acquisition Corp.

Symbol EUCRU

Primary Exchange

NASDAQ

ISIN VGG3141W1142

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Parag Phoolchand Saxena MBA, MS

Market Capitalization 47 Mio

Country United States of America

Currency USD

Employees -

Address 250 West 55th Street, 10019 New York City

IPO Date 2020-10-06

Ticker Symbols

Name	Symbol
NASDAQ	EUCRU

More Shares

Investors who hold EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT also have the following shares in their portfolio:

BCO LATINOA. 25/UND. FLR Bond

HSBC BANK PLC NTS LKD EUKAIROS PRF SRS 1665 14/04/27 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog